Search

Displaying results 7211 - 7220 of 8970 in total
  1. Drug

    Cloridarol

    go.drugbank.com/drugs/DB13291
    Experimental

    It was studied for the treatment of coronary insufficiency in Italy in the 1970s [A176222].

  2. Drug

    AUTO3

    go.drugbank.com/drugs/DB17364
    Investigational

    AUTO3 is bicistronic chimeric antigen receptor T-cell therapy investigated for acute lymphoblastic leukemia (ALL). … It is an investigational chimeric antigen receptor (CAR) T cell treatment targeting CD19 and CD22.

  3. Drug

    rAAV9-CMV-hNAGLUop

    go.drugbank.com/drugs/DB33959
    Experimental

    rAAV9-CMV-hNAGLUop is a biologic drug. rAAV9-CMV-hNAGLUop is under investigation in clinical trial NCT07818759 (Single Injection of rAAV9-CMV-hNAGLUop Gene for Patients With Mucopolysaccharidosis (MPS)

  4. Drug

    7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE

    go.drugbank.com/drugs/DB07512
    Experimental

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  5. Drug

    Guanosine-5'-Monophosphate

    go.drugbank.com/drugs/DB01972
    Experimental

    A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. [PubChem]

  6. Drug

    Morinidazole

    go.drugbank.com/drugs/DB15098
    Investigational

    Morinidazole is under investigation in clinical trial NCT03380793 (A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis).

  7. Drug

    Parathyroid Hormone-Related Protein 1-36

    go.drugbank.com/drugs/DB16278
    Investigational

    Parathyroid Hormone-Related Protein 1-36 is under investigation in clinical trial NCT00853723 (Comparison Study of Pthrp and PTH to Treat Osteoporosis).

  8. Drug

    Mecbotamab vedotin

    go.drugbank.com/drugs/DB17442
    Investigational

    Mecbotamab vedotin is an anti-Axl humanized monoclonal antibody conjugated to monomethyl auristatin E using a cleavable linker (CAB-Axl-ADC).[A255212]

  9. Drug

    TEL540-548

    go.drugbank.com/drugs/DB17461
    Investigational

    TEL540-548 is a recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT).

  10. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.